Ignite Creation Date:
2025-12-24 @ 11:47 PM
Ignite Modification Date:
2025-12-25 @ 9:41 PM
Study NCT ID:
NCT04985851
Status:
UNKNOWN
Last Update Posted:
2023-12-01
First Post:
2021-06-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
To Evaluate the Efficacy of Durvalumab + Anlotinib in Terms of OS and PFS.
Sponsor:
Shanghai Chest Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ESR-20-20841
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None